We have located links that may give you full text access.
Unsupervised rehabilitation: effects of exercise training over the long run.
Arquivos Brasileiros de Cardiologia 2002 September
OBJECTIVE: To assess the safety and efficacy of unsupervised rehabilitation (USR) in the long run in low-risk patients with coronary artery disease.
METHODS: We carried out a retrospective study with 30 patients divided into: group I (GI) - 15 patients from private clinics undergoing unsupervised rehabilitation; group II (GII) - control group, 15 patients from ambulatory clinic basis, paired by age, sex, and clinical findings. GI was stimulated to exercise under indirect supervision (jogging, treadmill, and sports). GII received the usual clinical treatment.
RESULTS: The pre- and postobservation values in GI were, respectively: VO2 peak (mL/kg/min), 24+/-5 and 31+/- 9; VO2 peak/peak HR: 0.18+/-0.05 and 0.28+/-0.13; peak double product (DP peak):26,800+/-7,000 and 29,000 +/- 6,500; % peak HR/predicted HRmax: 89.5+/-9 and 89.3+/-9. The pre- and post- values in GII were: VO2 peak (mL/kg/min), 27+/- 7 and 28+/-5; VO2 peak/peak HR: 0.2+/-0.06 and 0.2+/- 0.05; DP peak: 24,900+/-8,000 and 25,600+/- 8,000, and % peak HR/predicted HRmax: 91.3+/-9 and 91.1+/- 11. The following values were significant: preobservation VO2 peak versus postobservation VO2 peak in GI (p=0.0 063); postobservation VO2 peak in GI versus postobservation VO2 peak in GII (p=0.0045); postobservation VO2 peak/peak HR GI versus postobservation peak VO2/peak HR in GII (p=0.0000). The follow-up periods in GI and GII were, respectively, 41.33+/- 20.19 months and 20.60+/-8.16 months (p<0.05). No difference between the groups was observed in coronary risk factors, therapeutic management, or evolution of ischemia. No cardiovascular events secondary to USR were observed in 620 patient-months.
CONCLUSION: USR was safe and efficient, in low-risk patients with coronary artery disease and provided benefits at the peripheral level.
METHODS: We carried out a retrospective study with 30 patients divided into: group I (GI) - 15 patients from private clinics undergoing unsupervised rehabilitation; group II (GII) - control group, 15 patients from ambulatory clinic basis, paired by age, sex, and clinical findings. GI was stimulated to exercise under indirect supervision (jogging, treadmill, and sports). GII received the usual clinical treatment.
RESULTS: The pre- and postobservation values in GI were, respectively: VO2 peak (mL/kg/min), 24+/-5 and 31+/- 9; VO2 peak/peak HR: 0.18+/-0.05 and 0.28+/-0.13; peak double product (DP peak):26,800+/-7,000 and 29,000 +/- 6,500; % peak HR/predicted HRmax: 89.5+/-9 and 89.3+/-9. The pre- and post- values in GII were: VO2 peak (mL/kg/min), 27+/- 7 and 28+/-5; VO2 peak/peak HR: 0.2+/-0.06 and 0.2+/- 0.05; DP peak: 24,900+/-8,000 and 25,600+/- 8,000, and % peak HR/predicted HRmax: 91.3+/-9 and 91.1+/- 11. The following values were significant: preobservation VO2 peak versus postobservation VO2 peak in GI (p=0.0 063); postobservation VO2 peak in GI versus postobservation VO2 peak in GII (p=0.0045); postobservation VO2 peak/peak HR GI versus postobservation peak VO2/peak HR in GII (p=0.0000). The follow-up periods in GI and GII were, respectively, 41.33+/- 20.19 months and 20.60+/-8.16 months (p<0.05). No difference between the groups was observed in coronary risk factors, therapeutic management, or evolution of ischemia. No cardiovascular events secondary to USR were observed in 620 patient-months.
CONCLUSION: USR was safe and efficient, in low-risk patients with coronary artery disease and provided benefits at the peripheral level.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app